Find Clinical Trials
A randomised, double-blind, placebo- and olanzapine- controlled, parallel-group study to evaluate the efficacy and safety of 3 fixed doses of S 33138 in treatment of patients with an acute episode of Schizophrenia. A phase IIb, international, multicentre, 8-week study
Servier Protocol Code:
CL2-33138-011
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2006-006184-23
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Schizophrenia
- S033138
Other study id numbers
Other identification numbers the study may be known by.
- CL2-33138-011